Clinical Trial Update: Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating the efficacy of Tegaserod in relieving symptoms of irritable bowel syndrome in women, including IBS with constipation and IBS w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation
• Irritable Bowel Syndrome with Mixed Bowel Habits

Drugs mentioned

• Tegaserod (tegaserod)

Snippet

Sponsor: Novartis | Conditions: IBS-C and IBS With Mixed Bowel Habits | Phase 4 | Status: COMPLETED